Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings.
about
Natural killer cells and neuroblastoma: tumor recognition, escape mechanisms, and possible novel immunotherapeutic approachesNANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?Convergence of nanotechnology and cancer prevention: are we there yet?Combinatorial peptide libraries: mining for cell-binding peptides.Discovery of a polystyrene binding peptide isolated from phage display library and its application in peptide immobilization.Advances in phage display technology for drug discovery.Phage display: development of nanocarriers for targeted drug delivery to the brainLigand-targeted theranostic nanomedicines against cancerBacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos.Design of virus-based nanomaterials for medicine, biotechnology, and energy.Nanocarrier-mediated targeting of tumor and tumor vascular cells improves uptake and penetration of drugs into neuroblastoma.Anti-Tumor Effects of Bak-Proteoliposomes against Glioblastoma.Application of phage peptide display technology for the study of food allergen epitopes.A Proof-of-Concept for Epigenetic Therapy of Tissue Fibrosis: Inhibition of Liver Fibrosis Progression by 3-Deazaneplanocin A.Molecular galactose-galectin association in neuroblastoma cells: An unconventional tool for qualitative/quantitative screening.
P2860
Q26825652-45E5B206-8C6C-46AF-837D-63F80466A7D1Q28078448-E4909E6E-A249-4BAF-B85E-1D1A8749E475Q28386699-3ED596AE-3D81-47AB-AC40-998D0695CA04Q31144876-A4E629F2-B250-4AF9-BB30-9E598E0FC215Q33752993-E20D3362-B3BD-4443-8FFC-9D353F2E3268Q35614190-ADF2DD09-0328-4DD8-87AA-76357418AD2CQ35704834-6333E484-3BBE-4F21-A6DA-98E6AF84073BQ35895637-6247C356-3E07-4B28-9146-27A34AE32746Q35963673-BA2AA3A0-3EB5-4824-8DC4-41F59211A452Q37346447-4BD564F8-38C5-4954-A077-B31D0226A73CQ38128317-3EA3E58C-4676-480A-A11E-DE7708ECF52FQ38837839-BE14EAA5-68C2-4056-9F22-B0D13A6A40BBQ39044324-AFA614B7-29B2-486E-A5FF-FE91CA0FA95FQ45864008-DDBE6DCA-F3A1-4263-AB8E-F42526454ED0Q48875915-E5D23D0C-EA19-4AD2-AA94-79569D549D39
P2860
Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Novel phage display-derived ne ...... riers in preclinical settings.
@ast
Novel phage display-derived ne ...... riers in preclinical settings.
@en
type
label
Novel phage display-derived ne ...... riers in preclinical settings.
@ast
Novel phage display-derived ne ...... riers in preclinical settings.
@en
prefLabel
Novel phage display-derived ne ...... riers in preclinical settings.
@ast
Novel phage display-derived ne ...... riers in preclinical settings.
@en
P2093
P2860
P50
P1476
Novel phage display-derived ne ...... rriers in preclinical settings
@en
P2093
Chiara Brignole
Claudio Gambini
Jessica Sun
Laura Emionite
Marco Soster
Michele Cilli
Monica Sani
Pamela Becherini
Renata Pasqualini
Renato Longhi
P2860
P304
P356
10.1016/J.JCONREL.2013.04.029
P407
P50
P577
2013-05-25T00:00:00Z